Atenolol

Routes
Oral (PO)
Half-Life (t½)
PO: 6h
Formula
C14H22N2O3
Molecular Weight
266.34 g/mol
PubChem CID
2249
Aliases
Tenormin

Pharmacological Mechanism

Cardioselective β₁ antagonist; negligible β₂ at therapeutic doses. Hydrophilic → low CNS penetration (less nightmares / depression than propranolol). Renal elimination — accumulates in CKD.

Half-Life & Elimination Curve (PO: 6h)

100%50%25%12.5%0%0h0×t½6h1×t½12h2×t½18h3×t½24h4×t½30h5×t½0×t½ (0h): 100% remaining (~0.261 mg/L)1×t½ (6h): 50% remaining (~0.131 mg/L)2×t½ (12h): 25% remaining (~65.3 µg/L)3×t½ (18h): 12.5% remaining (~32.7 µg/L)4×t½ (24h): 6.3% remaining (~16.3 µg/L)5×t½ (30h): 3.1% remaining (~8.17 µg/L)
Plasma (PO)t½ Decay (6h)Effect Site (ke0)
  • 0×t½0h100% (0.261 mg/L)
  • 1×t½6h50% (0.131 mg/L)
  • 2×t½12h25% (65.3 µg/L)
  • 3×t½18h12.5% (32.7 µg/L)
  • 4×t½24h6.3% (16.3 µg/L)
  • 5×t½30h3.1% (8.17 µg/L)
Elimination t½6h (PO)
Rate Constant (ke)0.116 h⁻¹
Time to Peak (Tmax)3.08h
Est. Peak (Cmax)0.261 mg/L
Clearance (CL)7.74 L/h
97% Washout (5×t½)30h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References